TFRC and chronic myelogenous leukemia, BCR-ABL1 positive: Although it has been known for a long time that immune dysfunction is relevant in the development of CML [11] (reviewed in [12•]), only recently has it become the epicenter of research efforts whose aim is to identify the mechanisms of disease development and elucidate their relationship with TFR.